{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "15602689",
  "DateCompleted": {
    "Year": "2005",
    "Month": "05",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "11",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2004",
        "Month": "11",
        "Day": "10"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0946-2716",
      "JournalIssue": {
        "Volume": "82",
        "Issue": "12",
        "PubDate": {
          "Year": "2004",
          "Month": "Dec"
        }
      },
      "Title": "Journal of molecular medicine (Berlin, Germany)",
      "ISOAbbreviation": "J Mol Med (Berl)"
    },
    "ArticleTitle": "The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.",
    "Pagination": {
      "StartPage": "787",
      "EndPage": "799",
      "MedlinePgn": "787-99"
    },
    "Abstract": {
      "AbstractText": [
        "Body temperature regulation involves a homeostatic balance between heat production and dissipation. Sympathetic agents such as 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) can disrupt this balance and as a result produce an often life-threatening hyperthermia. The hyperthermia induced by MDMA appears to result from the activation of the sympathetic nervous system (SNS) and the hypothalamic-pituitary-thyroid/adrenal axis. Norepinephrine release mediated by MDMA creates a double-edged sword of heat generation through activation of uncoupling protein (UCP3) along with alpha1- and beta3-adrenoreceptors and loss of heat dissipation through SNS-mediated vasoconstriction. This review examines cellular mechanisms involved in MDMA-induced thermogenesis from UCP activation to vasoconstriction and how these mechanisms are related to other thermogenic conditions and potential treatment modalities."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "The National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892-1770, USA."
          }
        ],
        "LastName": "Mills",
        "ForeName": "Edward M",
        "Initials": "EM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rusyniak",
        "ForeName": "Daniel E",
        "Initials": "DE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sprague",
        "ForeName": "Jon E",
        "Initials": "JE"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "J Mol Med (Berl)",
    "NlmUniqueID": "9504370",
    "ISSNLinking": "0946-2716"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Carrier Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Hallucinogens"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Ion Channels"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Mitochondrial Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "UCP3 protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Uncoupling Protein 3"
    },
    {
      "RegistryNumber": "KE1SEN21RM",
      "NameOfSubstance": "N-Methyl-3,4-methylenedioxyamphetamine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "Body Temperature"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Carrier Proteins"
    },
    {
      "QualifierName": [
        "chemically induced",
        "metabolism",
        "physiopathology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Hallucinogens"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Ion Channels"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "Mitochondria"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mitochondrial Proteins"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "N-Methyl-3,4-methylenedioxyamphetamine"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Sympathetic Nervous System"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Uncoupling Protein 3"
    }
  ],
  "NumberOfReferences": "162"
}